Preventive treatment is now available for the respiratory syncytial virus, which affects 64 million people annually. But drug ...
Both shots were approved earlier this year--the first RSV vaccines after decades of unsuccessful attempts--and the third quarter was the first full quarter for which sales were reported. GSK said ...
EAST HARTFORD — U.S. Sen. Richard Blumenthal on Monday called for two government-approved manufacturers of the respiratory ...
At a meeting at the White House on Monday, officials and manufacturers also agreed to plan now to meet next year’s demand for ...
American pharmaceutical giant filed application for regulatory approval of its Abrysvo jab in Hong Kong last month, source familiar with situation says.
A: The CDC has authorized two RSV vaccines for the prevention of lower respiratory tract disease in people 60 and older. The ...
Respiratory syncytial virus, or RSV, is a common respiratory virus that spreads seasonally. A new drug and several vaccines that prevent the infection have recently come to market. Here's what you ...
Despite 50 years of research, there are currently no RSV vaccines approved or in Phase III trials for any of the target populations. High levels of neutralizing antibodies to RSV F protein have ...
New vaccines against RSV are now available in Waco for the elderly and those who are pregnant regardless of income or insurance. “It is critical that older adults, 60 years and up, get ...
Besides Pfizer’s fast-declining COVID-19 sales, vaccine rival GSK is giving the New York drugmaker another reason to worry. In the first round of their RSV vaccine showdown, GSK’s Arexvy ...
CARMEL, Ind. (Ivanhoe Newswire) – Respiratory syncytial virus, or RSV, is a common illness among young kids. Eighty percent of babies catch it within their first year of life. For some, it can ...
As cold and flu season ramps up, health care experts are once again on high alert for the possibility of a tripledemic, or a surge brought on by the respiratory viruses that cause COVID-19, the flu ...
